呼吸衰竭的预测因素和1型肌性缩症的生存率
Marie-Anne Melone1,2, Ivana Dabaj3, Maxime Patout4,5,6
1Normandie Univ, UNIROUEN, CHU Rouen, AIMS, Nord/Est/Ile de France Neuromuscular Diseases Reference Center, CHU Rouen, FILNEMUS, Department of Pulmonary, Thoracic Oncology and Respiratory Intensive Care, Rouen, France.
Journal of neuromuscular diseases
|October 21, 2025
概括
在1型肌肉性缩症 (DM1) 患者早期发现肌肉损伤和心脏问题,可以预测呼吸系统问题和死亡率. 这些标志物对于改善患者生存率至关重要.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 肺部病理学 肺部病理学
背景情况:
- 肌性衰竭1型 (DM1) 导致肌肉逐渐衰弱和危及生命的慢性呼吸衰竭 (CRF).
- 早期识别患有CRF风险的患者是具有挑战性的.
研究的目的:
- 确定临床和生物标志物,预测大量DM1队列中CRF发病和存活率.
- 为DM1患者的临床管理策略提供信息.
主要方法:
- 从2000年到2024年,对126名成年DM1患者进行了回顾性队列研究.
- 主要结局:预测强迫生命能力 (FVC) ≤70%.
- 使用具有竞争风险的考克斯比例危险模型分析的预测因素.
主要成果:
- 肌肉损伤评分表 (MIRS) 和心脏导电/心律障碍在诊断时预测FVC下降.
- CTG重复次数≥400显示,呼吸系统衰退风险增加的趋势.
- 在MIRS中,男性性别和诊断时的年龄较大预测了死亡率 (32%的20年率).
结论:
- 肌肉衰弱和心脏疾病是DM1中呼吸道并发症的强烈预测因素.
- 女士,男性性别和诊断时的年龄较大预测死亡率.
- 这些预后标记可以指导临床管理,以改善DM1患者的生存率.
相关概念视频
Acute Respiratory Failure-III
768
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
768
Acute Respiratory Failure-V
451
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
451
Assessment of Airway, Skin Color, and Use of Accessory Muscles
1.6K
A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
Introduction
The initial evaluation of a patient's respiratory system...
1.6K
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-I
832
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
832
Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K


